| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/16/2004 | EP1218401B1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 06/16/2004 | EP1058552B1 Steroid derived antibiotics |
| 06/16/2004 | CN1153778C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 06/09/2004 | CN1152847C Method for prepn. of steroid derivative ketal |
| 06/08/2004 | US6747018 Treatment of estrogen-dependent disorders; preferred compounds have 1,3,5-estratriene nucleus, and are substituted at c-17 or c-11 with molecular moiety which renders compounds effective to block binding of estrogen to its receptor |
| 06/03/2004 | US20040106154 In vivo screen using chemical inducers of dimerization |
| 05/27/2004 | WO2002090375A8 Liver x receptor agonists |
| 05/27/2004 | US20040102425 Selective glucocorticoid receptor agonists |
| 05/25/2004 | US6740645 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1420027A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1341805B1 Method for the production of 4-(17-alpha-alkoxymethyl-17-beta-substituted 3-oxoestra-4,9-dien-11-beta-yl)benzaldehyd-(1e)-oxime derivatives |
| 05/19/2004 | CN1498222A Steroidal derivatives |
| 05/13/2004 | US20040093165 Estrogen receptor ligands |
| 05/13/2004 | US20040092492 Reacting a corresponding aldehyde with hydroxylamine compound forming oxime group |
| 05/06/2004 | WO2004011663A9 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 05/06/2004 | US20040087565 Hormone replacement therapy |
| 05/06/2004 | EP0775155B1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 04/29/2004 | WO2003086303A3 Farnesoid x-activated receptor agonists |
| 04/29/2004 | WO2003027132A8 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES |
| 04/29/2004 | US20040082556 Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
| 04/29/2004 | US20040081687 Cholesterol group is linked to the optional linker group via a carbamoyl linkage and then linked to carbohydrate |
| 04/28/2004 | CN1492876A Amphoteric sterols and the use thereof |
| 04/15/2004 | WO2003068736A3 Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof |
| 04/14/2004 | CN1489597A N-oxy-group-contained lipids |
| 04/08/2004 | WO2004007522A3 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 04/08/2004 | WO2004001369A3 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |
| 04/08/2004 | WO2003087121A8 Branched polyamine steroid derivatives |
| 04/07/2004 | EP1405860A1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/07/2004 | EP1404701A1 Method for preparing oestrogen derivatives |
| 04/07/2004 | EP1404700A2 Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation and intermediates of this process |
| 04/07/2004 | CN1144813C Noval pregnane derivatives without substituting group at 17šŒlpha position, itsapplication as medicine preparing method and intermediate thereof and related compounds |
| 04/01/2004 | WO2003095471A3 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 04/01/2004 | WO2003089449A3 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 04/01/2004 | US20040063172 Therapy for hormone sensitive diseases; contraceptives |
| 03/31/2004 | EP1401856A2 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds |
| 03/30/2004 | CA2243504C New 19-nor-pregnene derivatives |
| 03/25/2004 | US20040059141 Reacting a bezaldoxime derivative with chloroformic acid trichloromethyl ester or phosgen in an inert solvent in presence of tert-amines to form an intermediate, reacting intermediate with an alcohol or thioalcohol or an amine |
| 03/24/2004 | CN1142939C Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 03/18/2004 | US20040053905 Method for the production of 4-(17$g(a) substituted 3-oxoestra-4,9-dien-11$g(b)-yl) benzaldehyd-(1e or 1z)-oximes |
| 03/18/2004 | US20040053896 Pharmaceutically active compound |
| 03/17/2004 | CN1142175C Sulfurization for oestrogen mixture |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/11/2004 | US20040048838 Meiosis regulating compounds |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/10/2004 | EP1395544A1 Methods of making 21- 4'-(nitrooxyalkyl) benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/03/2004 | EP1392713A2 Liver x receptor agonists |
| 03/03/2004 | EP1042354B1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 03/03/2004 | CN1479746A Process and intermediates for production of 7-substituted antiestrogens |
| 02/26/2004 | WO2003064443A3 New corticosteroids |
| 02/26/2004 | WO2003026568A3 Androstanes as androgen receptor modulators |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/24/2004 | US6696592 Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 02/24/2004 | US6696580 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 02/19/2004 | WO2004014935A1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 02/19/2004 | WO2003070745B1 Carbonate and carbamate modified forms of glucocorticoids |
| 02/19/2004 | US20040034216 A gonane ring or with the nitrogen forming a heterocyclic structure; antiinflammation agents, antitumor agents; treating asthma, allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, AIDS, arrhythmias |
| 02/19/2004 | DE10236405A1 New 4-(3-oxo-estra-4,9-dien-11 beta-yl)-benzaldehyde oximes, are progesterone receptor modulators useful in female contraception, hormone replacement therapy and treatment of gynecological disorders |
| 02/18/2004 | EP1389623A2 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds |
| 02/18/2004 | CN1138811C Double metal cyanide catalyst for producing polyether polyols |
| 02/17/2004 | US6693090 19-norsteroids substituted in position 11β, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them |
| 02/12/2004 | WO2004013086A1 Photoactive materials |
| 02/12/2004 | WO2004012686A2 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | DE10233723A1 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids |
| 02/11/2004 | EP0832094B1 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 02/11/2004 | CN1474829A Method for production of 4-(17 alpha-substituted-3-oxoestra-4,9-dien-11-yl) benzaldehyd-(1E or 12)-oximes |
| 02/05/2004 | WO2004011663A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 02/05/2004 | WO2004011528A1 Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display |
| 02/05/2004 | US20040023936 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 02/04/2004 | EP1386910A1 Photoactive materials |
| 02/04/2004 | EP1385868A2 Steroidal derivatives |
| 01/29/2004 | WO2003053992A3 Industrially applicable process for the sulfamoylation of alcohols and phenols |
| 01/29/2004 | US20040019200 Cycloalkyl-spiro-1, 2,4,5-tetraoxacyclohexane-spiro-cholic acids and derivatives; antiprotozoa agents, bactericides and antitumor agents |
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/28/2004 | EP0918790B1 Polycationic sterol derivatives as transfection agents |
| 01/22/2004 | WO2004007522A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 01/22/2004 | US20040014781 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/22/2004 | US20040014734 Anticholesterol agents |
| 01/20/2004 | CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 01/15/2004 | US20040010099 Initiator systems, polymerisable compositions, and uses thereof for bonding low surface energy substrates |
| 01/15/2004 | DE10226326A1 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene 9-alpha-substiuierte estratrienes as selective estrogens effective |
| 01/14/2004 | EP1379254A1 Use of bile acid or bile salt fatty acid conjugates |
| 01/13/2004 | US6677374 Nervous system disorders |
| 01/13/2004 | US6677325 Steroid sulphatase inhibitors |
| 01/08/2004 | US20040006241 For use in female birth control, for therapy of hormone-dependent gynecological disorders and for hormone replacement therapy |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/07/2004 | EP1377673A2 Glycosilated cationic lipids for liposomes used in drug delivery |
| 01/07/2004 | CN1133643C Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives |
| 01/06/2004 | US6673555 Methods of using SCAP antagonists |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 12/31/2003 | WO2004001369A2 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |
| 12/31/2003 | WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 12/31/2003 | WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly |
| 12/31/2003 | WO2003047549A3 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety |
| 12/31/2003 | CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly |